These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
662 related items for PubMed ID: 33539543
1. Fresh versus frozen embryo transfers in assisted reproduction. Zaat T, Zagers M, Mol F, Goddijn M, van Wely M, Mastenbroek S. Cochrane Database Syst Rev; 2021 Feb 04; 2(2):CD011184. PubMed ID: 33539543 [Abstract] [Full Text] [Related]
3. Number of embryos for transfer following in vitro fertilisation or intra-cytoplasmic sperm injection. Kamath MS, Mascarenhas M, Kirubakaran R, Bhattacharya S. Cochrane Database Syst Rev; 2020 Aug 21; 8(8):CD003416. PubMed ID: 32827168 [Abstract] [Full Text] [Related]
4. Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technology. Youssef MA, Van der Veen F, Al-Inany HG, Mochtar MH, Griesinger G, Nagi Mohesen M, Aboulfoutouh I, van Wely M. Cochrane Database Syst Rev; 2014 Oct 31; 2014(10):CD008046. PubMed ID: 25358904 [Abstract] [Full Text] [Related]
7. Recombinant luteinizing hormone (rLH) and recombinant follicle stimulating hormone (rFSH) for ovarian stimulation in IVF/ICSI cycles. Mochtar MH, Danhof NA, Ayeleke RO, Van der Veen F, van Wely M. Cochrane Database Syst Rev; 2017 May 24; 5(5):CD005070. PubMed ID: 28537052 [Abstract] [Full Text] [Related]
8. Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro fertilisation plus intracytoplasmic sperm injection (IVF/ICSI). Lensen SF, Wilkinson J, Leijdekkers JA, La Marca A, Mol BWJ, Marjoribanks J, Torrance H, Broekmans FJ. Cochrane Database Syst Rev; 2018 Feb 01; 2(2):CD012693. PubMed ID: 29388198 [Abstract] [Full Text] [Related]
9. Volume expanders for the prevention of ovarian hyperstimulation syndrome. Youssef MA, Mourad S. Cochrane Database Syst Rev; 2016 Aug 31; 2016(8):CD001302. PubMed ID: 27577848 [Abstract] [Full Text] [Related]
10. Long-term GnRH agonist therapy before in vitro fertilisation (IVF) for improving fertility outcomes in women with endometriosis. Georgiou EX, Melo P, Baker PE, Sallam HN, Arici A, Garcia-Velasco JA, Abou-Setta AM, Becker C, Granne IE. Cochrane Database Syst Rev; 2019 Nov 20; 2019(11):. PubMed ID: 31747470 [Abstract] [Full Text] [Related]
11. Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro fertilisation plus intracytoplasmic sperm injection (IVF/ICSI). Ngwenya O, Lensen SF, Vail A, Mol BWJ, Broekmans FJ, Wilkinson J. Cochrane Database Syst Rev; 2024 Jan 04; 1(1):CD012693. PubMed ID: 38174816 [Abstract] [Full Text] [Related]
12. Day three versus day two embryo transfer following in vitro fertilization or intracytoplasmic sperm injection. Brown J, Daya S, Matson P. Cochrane Database Syst Rev; 2016 Dec 14; 12(12):CD004378. PubMed ID: 27976360 [Abstract] [Full Text] [Related]
13. Application of seminal plasma to female genital tract prior to embryo transfer in assisted reproductive technology cycles (IVF, ICSI and frozen embryo transfer). Ata B, Abou-Setta AM, Seyhan A, Buckett W. Cochrane Database Syst Rev; 2018 Feb 28; 2(2):CD011809. PubMed ID: 29489026 [Abstract] [Full Text] [Related]